RUNX2 and breast carcinoma: Although these results are concordant with a small study showing that RUNX2 is absent in ER+ breast cancer (Onodera et al., 2010), they contrast to one in which RUNX2 expression was specifically found in ER+ tumours (Das et al., 2009).